Dea No. 1680
Dea No. 1680 Brand names, Dea No. 1680 Analogs
Dea No. 1680 Brand Names Mixture
- No information avaliable
Dea No. 1680 Chemical_Formula
C15H15NO2S
Dea No. 1680 RX_link
http://www.rxlist.com/cgi/generic2/modafinil.htm
Dea No. 1680 fda sheet
Dea No. 1680 msds (material safety sheet)
Dea No. 1680 Synthesis Reference
L. Lafon, U.S. pat. 4,927,855, (1990)
Dea No. 1680 Molecular Weight
273.351 g/mol
Dea No. 1680 Melting Point
164-166 oC
Dea No. 1680 H2O Solubility
Slightly soluble
Dea No. 1680 State
Solid
Dea No. 1680 LogP
1.736
Dea No. 1680 Dosage Forms
Tablet
Dea No. 1680 Indication
To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.
Dea No. 1680 Pharmacology
Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. Modafinil is not indicated for complaints of lack of energy or fatigue; but it appears to be very helpful for some patients. Also, it has been used in the treatment of hypersomnia, a disorder in which patients lack the capacity for meaningful sleep and may require ten or more hours per day. Recent studies have have found that modafinil may help recovering cocaine addicts fight their addiction.
Dea No. 1680 Absorption
Rapid following oral administration.
Dea No. 1680 side effects and Toxicity
No information avaliable
Dea No. 1680 Patient Information
Dea No. 1680 Organisms Affected
Humans and other mammals
